Kristine T. Kingsley, PsyD, ABPP-Rp
Owner & Managing Director
Institute of Cognitive and Emotional Wellness
New Rochelle, New York
Amanda Sacks-Zimmerman, PhD, ABPP-CN
Neurological Surgery Weill Cornell Medicine
New York, New York
Mounting evidence suggests that patients surviving COVID-19 face neurocognitive and psychosocial effects that extend for long periods of time. The purpose of this symposium is to present recent evidence on the effects of COVID-19 on the central nervous system and direction for assessment and treatment. We will address the need for developing a sensitive battery to detect neurocognitive and psychosocial effects through integration of knowledge from other COVID-19 research and from conditions with similar effects. We will discuss potential phenotypes of neurocognitive-neuropsychiatric profiles based on current knowledge from COVID-19 research and lessons learned from previous SARS pandemics. The symposium will integrate the above knowledge and provide case examples of mental health needs and rehabilitation efforts in different settings, using evidence-based methodologies from conditions that generate similar rehabilitation challenges. The symposium will conclude with cultural considerations and emerging disparities as well as funding consideration from different health systems around the globe.